Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Modafinil
Sigma Pharmaceuticals Plc
N06BA07
Modafinil
100mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04040000
Adobe InDesign CC JB V 10.InD Cutterguide Black Provigil 100/200mg tabs ALL SpUK Macors (A) V4 60026 Leaflet 157x420mm N/A Font NewsGoth BT Body Size 10pt MW 21-6-19 3.0 DS 2-7-19 PACKAGE LEAFLET: INFORMATION FOR THE USER PROVIGIL ® 100 MG TABLETS PROVIGIL ® 200 MG TABLETS modafinil READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What PROVIGIL is and what it is used for 2. What you need to know before you take PROVIGIL 3. How to take PROVIGIL 4. Possible side effects 5. How to store PROVIGIL 6. Contents of the pack and other information 1. WHAT PROVIGIL IS AND WHAT IT IS USED FOR The active ingredient in the tablets is modafinil. Modafinil can be taken by adults who suffer from narcolepsy to help them to stay awake. Narcolepsy is a condition that causes excessive daytime sleepiness and a tendency to fall asleep suddenly in inappropriate situations (sleep attacks). Modafinil may improve your narcolepsy and reduce the likelihood that you will have sleep attacks but there may still be other ways that you can improve your condition and your doctor will advise you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PROVIGIL DO NOT TAKE PROVIGIL: • if you are ALLERGIC to modafinil or any of the other ingredients of this medicine (listed in section 6). • if you have an IRREGULAR HEARTBEAT. • if you have UNCONTROLLED, MODERATE TO SEVERE HIGH BLOOD PRESSURE (hypertension). WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking PROVIGIL if you: • Have any HEART PROBLEMS or HIGH BLOOD Read the complete document
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT100 mg tablets Read the complete document200 mg tablets> 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 100 mg of modafinil. Excipient(s) with known effect: Each tablet contains 68 mg of anhydrous lactose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. The tablets are white to off-white, 13 x 6 mm, capsule-shaped and debossed with ‘100’ on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS < Invented name> is indicated in adults for the treatment of excessive sleepiness associated with narcolepsy with or without cataplexy. Excessive sleepiness is defined as difficulty maintaining wakefulness and an increased likelihood of falling asleep in inappropriate situations. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment should be initiated by or under the supervision of a physician with appropriate knowledge of indicated disorders (see section 4.1). A diagnosis of narcolepsy should be made according to the International Classification of Sleep Disorders (ICSD2) guideline. Patient monitoring and clinical assessment of the need for treatment should be performed on a periodic basis. Posology 3 The recommended starting daily dose is 200 mg. The total daily dose may be taken as a single dose in the morning or as two doses, one in the morning and one at noon, according to physician assessment of the patient and the patient's response. Doses of up to 400 mg in one or two divided doses can be used in patients with insufficient response to the initial 200 mg modafinil dose. Long-term use Physicians prescribing modafinil for an extended time should periodically re-evaluate the long-term use for the individual patients as the long-term efficacy of modafinil has not been evaluated (> 9 week